BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Monoclonal Antibodies for COVID-19 in Africa: Promise and Pitf
 alls
X-WR-TIMEZONE:Pacific Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260916T025957Z
UID:tag:localist.com\,2008:EventInstance_35291877810757
DTSTART:20201210T150000Z
DTEND:20201210T163000Z
DESCRIPTION:Please join us for a discussion with global health experts on t
 he use of monoclonal antibodies to fight COVID-19 in Africa. While the wor
 ld has mobilized at unprecedented speed to develop effective vaccines\, it
  will still take time for widespread vaccine distribution and immunization
 \, particularly in the lower income countries. Complementary solutions\, s
 uch as effective therapeutics\, are urgently needed to mitigate the toll o
 f the pandemic in Africa. Technologies that we develop now during the COVI
 D-19 pandemic also have the potential to aid in future pandemics. \n\nRegi
 ster at: https://globalhealthsciences.ucsf.edu/event/monoclonal-antibodies
 -covid-19-africa-promise-and-pitfalls-digital-panel-and-forum\n\nWith the 
 recent commitment by the Bill and Melinda Gates Foundation and Eli Lilly a
 nd Company to procure monoclonal antibodies for low- and middle-income cou
 ntries\, there is a need to identify how\, when and where these drugs shou
 ld be used. Significant hurdles to effective deployment exist\, including 
 highly technical manufacturing and limited production\, cold chain require
 ments\, high prices and efficacy likely limited to specific populations. \
 n\nPanelists will discuss the obstacles to efficiently\, effectively\, and
  equitably rolling out monoclonal antibodies for COVID-19 across Africa an
 d identify possible solutions for addressing these challenges. The webinar
  will be hosted by the Pandemic Response Initiative at the University of C
 alifornia San Francisco Institute for Global Health Sciences.\n\nHost\n\nP
 rofessor Sir Richard Feachem\, KBE\, FREng\, DSc(Med)\, PhD \nDirector\, G
 lobal Health Group and Professor of Global Health\, Institute for Global H
 ealth Sciences\, University of California San Francisco\n\n \n\nModerator\
 n\nKelly C. Sanders\, MD\, MS \n\nTechnical Lead\, Pandemic Response Initi
 ative\, Institute for Global Health Sciences\, University of California Sa
 n Francisco\n\n \n\nPanelists\n\nBernice T. Dahn\, MD\, MPH \n\nVice Presi
 dent for Health Sciences\, University of Liberia \n\nFormer Minister of He
 alth for the Republic of Liberia \n\n \n\nProfessor Sir Jeremy Farrar\, OB
 E\, FMedSci\, FRS \n\nDirector\, Wellcome Trust\n\nCo-Chair\, Access to CO
 VID-19 Tools Accelerator\n\n \n\nDean Pettit\, PhD\n\nAffiliate Professor\
 , University of Washington\, Bioengineering\n\nSr VP\, Biotherapeutic Scie
 nce at Just-Evotec Biologics \n\n \n\nFatima Suleman\, BPharm\, MPharm\, P
 hD \n\nUniversity of Kwa-Zulu Natal \n\nWorld Health Organization Collabor
 ating Centre for Pharmaceutical\n\n \n\nPrashant Yadav\, PhD\, MBA \n\nSen
 ior Fellow\, Center for Global Development\; Affiliate Professor\, INSEAD\
 n\n \n\nDiscussant\n\nGeorge B. Kyei\, MD\, PhD\, MS \n\nInternal Medicine
  and Infectious Disease Physician\, University of Ghana \n\n \n\nClosing R
 emarks\n\nTrevor Mundel\, MBBCh\, PhD\, MSc \n\nPresident of Global Health
 \, Bill & Melinda Gates Foundation
LOCATION:
SUMMARY:Monoclonal Antibodies for COVID-19 in Africa: Promise and Pitfalls
URL;VALUE=URI:https://calendar.ucsf.edu/event/monoclonal_antibodies_for_cov
 id-19_in_africa_promise_and_pitfalls
END:VEVENT
END:VCALENDAR